Additionally, since clinical data obtained from TCGA are incomplete, such as the high proportion of Mx in the M stage, we cannot compare the expression level of PLEK2 in the HNSCC metastatic non‐metastatic group, respectively. Here, PLEK2 is linked to head and neck squamous cell carcinoma.